Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PQTV | ISIN: SE0011178458 | Ticker-Symbol: KN0
Frankfurt
20.11.24
11:06 Uhr
0,024 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
DICOT PHARMA AB Chart 1 Jahr
5-Tage-Chart
DICOT PHARMA AB 5-Tage-Chart

Aktuelle News zur DICOT PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiDicot Pharma AB: First participants dosed in Dicot Pharma's Phase 2a clinical study-Uppsala, Sweden, November 20, 2024. The first participants in Dicot Pharma's Phase 2a clinical study have now been dosed. The company's drug candidate LIB-01 is being developed as a new first-line treatment...
► Artikel lesen
DiDICOT PHARMA AB: International business development expert joins Dicot Pharma1
DICOT PHARMA Aktie jetzt für 0€ handeln
08.11.DICOT PHARMA AB: Dicot Pharma announces initiation of Phase 2a clinical study1
06.11.Nasdaq Stockholm AB: Listing of Dicot Pharma AB on Nasdaq First North Growth Market Sweden145On request of Dicot Pharma AB, company registration number 559006-3490, Nasdaq Stockholm AB has admitted the company's shares and equity rights to trading on Nasdaq First North Growth Market Sweden...
► Artikel lesen
06.11.DICOT PHARMA AB: Dicot Pharma listed on Nasdaq First North3
01.11.Spotlight Stock Market: Market Notice 222/24 - Dicot Pharma AB will be delisted after close of the market on November 6, 20241
31.10.DICOT PHARMA AB: Dicot Pharma presents interim report Q3 20241
23.10.DICOT PHARMA AB: Dicot Pharma has received conditional approval for listing on Nasdaq First North Growth Market Stockholm with preliminary first day of trading November 7, 20244
22.10.DICOT PHARMA AB: Dicot Pharma's results attract great attention in the US3
21.10.DICOT PHARMA AB: Dicot Pharma receives approval to start Phase 2a clinical trial2
16.10.Nomination Committee appointed for Dicot Pharma AB2
14.10.DICOT PHARMA AB: Dicot Pharma informs that two additional patents are in the process of being approved in USA2
11.10.DICOT PHARMA AB: Dicot Pharma receives Notice of Allowance for patent application in the US4
24.09.DICOT PHARMA AB: Dicot Pharma towards listing on Nasdaq First North3
17.09.DICOT PHARMA AB: Dicot Pharma provides an operational update2
11.09.Spotlight Stock Market: Market Notice 180/24 Information regarding Dicot Pharma AB's subscription option1
09.09.DICOT PHARMA AB: Dicot Pharma carries out a directed issue of units to guarantors, where 99.2 percent chose remuneration in units1
09.09.Spotlight Stock Market: Market Notice 177/24 - Last day of trading in Dicot AB's BTU1
09.09.DICOT PHARMA AB: Dicot Pharma announces last day of trading in BTU and first day of trading for warrants series TO 62
04.09.DICOT PHARMA AB: Dicot Pharma's rights issue oversubscribed1
Seite:  Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1